脂联素影响体外培养肝细胞乙醛氧化酶1表达的研究

摘要/Abstract

摘要： 目的研究脂联素（APN）对饱和脂肪酸(SFA)孵育HepG2细胞及HL-7701肝细胞乙醛氧化酶1（AOX1）分泌的影响，探讨APN对非酒精性脂肪肝脏病变（NAFLD）的治疗效果及机制。方法采用100 μmol/L SFA孵育细胞得到脂肪性HepG2细胞及HL-7701细胞，同时设立细胞对照组（未经100 μmol/L饱和脂肪酸孵育）。然后采用不同浓度APN（0.5、1.0、1.5、2.5 μg/mL）孵育脂肪性HepG2细胞及HL-7701细胞，将未经APN孵育的细胞作为对照。运用逆转录聚合酶链反应（RT-PCR）检测2种细胞AOX1基因表达，运用免疫印迹法检测2种细胞AOX1蛋白表达。结果与未经100 μmol/L SFA孵育的对照组比较，经100 μmol/L SFA孵育过的HepG2细胞及HL-7701细胞的AOX1基因及蛋白表达均明显增加（P<0.05），且HepG2细胞组明显高于HL-7701细胞组（P<0.05）。加入APN孵育细胞后，2种细胞AOX1基因及蛋白表达均明显低于未经APN孵育的对照组（P<0.05）；并且随APN浓度升高，降幅增加。当APN浓度达到1.5 μg/mL时，细胞AOX1表达的降低不再随APN浓度的增加而发生明显变化。在APN浓度相同的条件下，HepG2细胞组中AOX1基因及蛋白表达降低的幅度明显高于HL-7701细胞组。结论 APN能有效降低脂肪化肝脏细胞AOX1基因及蛋白表达，能很好的保护肝脏细胞，避免肝脏细胞发生NAFLD。

关键词: 脂联素, 乙醛氧化酶1, HepG2肝癌细胞株, HL-7701肝细胞株, 非酒精性脂肪肝脏病变

Abstract: Objective To investigate the influence of adiponectin（APN） on aldehyde oxidase-1 （AOX1） expression of HepG2 hepatoma cell lines and HL-7701 hepatic cell lines incubated by saturated fatty acid (SFA), and discuss the curative effect and possible mechanism of APN to protect non-alcohol fatty liver disease（NAFLD）. Methods Fatty HepG2 hepatoma cell lines and HL-7701 hepatic cell lines were incubated by 100 μmol/L SFA, and cells without being incubated by 100 μmol/L SFA were as controls. The fatty HepG2 hepatoma cell lines and HL-7701 hepatic cell lines were performed the treatment of APN (0.5,1.0,1.5 and 2.5 μg/mL), and cells without APN treatment were used as control group. Reverse transcription-polymerase chain reaction（RT-PCR） and Western-blot were utilized to detect the expressions of AOX1 gene and AOX1 protein. Results The AOX1 gene and AOX1 protein expressions of cells incubated by 100 μmol/L SFA were significantly higher than those of controls without being incubated by 100 μmol/L SFA (P<0.05), and the expression of HepG2 cells was significantly higher than that of HL-7701 cells (P<0.05). The AOX1 gene and AOX1 protein expressions of cells treated by APN were reduced significantly comparing to those without APN treatment (P<0.05)， which indicated that APN could decrease the expression effectively. However， the AOX1 expression of cells had no change, when the APN concentration reached 1.5 μg/mL. The AOX1 gene and AOX1 protein expressions of HepG2 cells decreased significantly higher than those of HL-7701 cells at the same APN concentration. Conclusions APN could reduce the expression of cells incubated by saturated fatty acid effectively， therefore it could protect hepatic cells from NAFLD.

Key words: Adiponectin, Aldehyde oxidase-1, HepG2 hepatoma cell line, HL-7701 hepatic cell line, Non-alcohol fatty liver disease

张亮;陈志强;文剑. 脂联素影响体外培养肝细胞乙醛氧化酶1表达的研究[J]. 检验医学, 2012, 27(4): 275-279.

ZHANG Liang;CHEN Zhiqiang;WEN Jian. Investigation on the effects of Adiponectin on Aldehyde oxidase-1 expression of hepatic cell lines in vitro[J]. , 2012, 27(4): 275-279.

参考文献

［1］ Buechler C, Wanninger J, Neumeier M. Adiponectin receptor binding proteins-recent advances in elucidating adiponectin signalling pathways［J］. FEBS Lett，2010，584（20）: 4280-4286.

［2］ Hui CK， Zhang HY， Lee NP， et al. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B［J］. J Hepatol，2007，47（2）: 191-202.

［3］ Bianchi G， Bugianesi E， Frystyk J， et al. Adiponectin isoforms， insulin resistance and liver histology in nonalcoholic fatty liver disease［J］. Dig Liver Dis，2011，43（1）: 73-77.

［4］ Pelletier J, Bozzolan F, Solvar M, et al. Identification of candidate aldehyde oxidases from the silkworm Bombyx mori potentially involved in antennal pheromone degradation［J］. Gene，2007， 404（1-2）: 31-40.

［5］ Sorouraddin MH, Fooladi E, Naseri A, et al. A novel spectrophotometric method for determination of kinetic constants of aldehyde oxidase using multivariate calibration method［J］. J Biochem Biophys Methods，2008，70（6）: 999-1005.

［6］张亮，陈志强，文剑，等.脂联素对体外培养肝细胞乙醛氧化酶1分泌的影响［J］. 检验医学，2008，23（4）: 349-353.

［7］ Ge K， Cho YW， Guo H， et al. Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor gamma-stimulated adipogenesis and target gene expression［J］. Mol Cell Biol, 2008, 28(3):1081-1091.

［8］ Oh DK， Ciaraldi T， Henry RR. Adiponectin in health and disease［J］. Diabetes Obes Metab, 2007,9(3):282-289.

［9］ Inoue Y, Itou T, Jimbo T, et al. Molecular cloning and identification of bottle-nosed dolphin p40(phox)， p47(phox) and p67(phox)［J］. Vet Immunol Immunopathol，2001，78（1）: 21-33.

［10］ Tacke F, Wüstefeld T, Horn R, et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo［J］. J Hepatol，2005，42（5）: 666-673.

［11］ Takano H， Obata JE， Kodama Y， et al. Adiponectin is released from the heart in patients with heart failure［J］. Int J Cardiol，2009，132（2）: 221-226.

［12］〖JP4〗Hammana I，Malet A，Costa M，et al. Normal adiponectin levels despite abnormal glucose tolerance（or diabetes） and inflammation in adult patients with cystic fibrosis［J］. Diabetes Metab， 2007， 33（3）: 213-219.

［13］ Yang B， Chen L， Qian Y， et al. Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats［J］. Biochem Biophys Res Commun， 2006， 341（1）: 209-217.

［14］ Al-Gubory KH, Fowler PA, Garrel C. The roles of cellular reactive oxygen species， oxidative stress and antioxidants in pregnancy outcomes［J］. Int J Biochem Cell Biol，2010，42（10）: 1634-1650.

［15］ Buonocore G, Perrone S, Tataranno ML. Oxygen toxicity: chemistry and biology of reactive oxygen species［J］. Semin Fetal Neonatal Med，2010，15（4）:186-190.

［16］ Tang H, Sebastian BM, Axhemi A, et al. Ethanol-induced oxidative stress via the CYP2E1 pathway disrupts adiponectin secretion from adipocytes［J］. Alcohol Clin Exp Res，2012，36（2）:214-222.

［17］〖JP+2〗Berg AH， Combs TP， Du X， et al. The adiocyte-secereted protein Acrp 30 enhances hepatic insulin action［J］. Nat Med，2001，7(8):947-953.

[1]	郭卫东, 付云, 高尚兰. 血浆APN、sRAGE与ARDS患者预后的关系[J]. 检验医学, 2021, 36(11): 1097-1100.
[2]	周中卫, 居会祥, 金浩, 陈红梅, 孙明忠. 胎球蛋白A/脂联素比值在2型糖尿病合并代谢综合征中的价值[J]. 检验医学, 2020, 35(5): 414-419.
[3]	徐黎明, 沈军. 血清瘦素和脂联素联合检测在狼疮性肾炎诊断中的价值[J]. 检验医学, 2019, 34(5): 401-404.
[4]	孙继红, 张艳, 路海荣, 孙涛, 剌梅, 慕军平, 钱姣, 沈建华. 脂联素等脂类指标与中老年人群甲状腺功能紊乱的相关性分析[J]. 检验医学, 2016, 31(7): 549-552.
[5]	邵小群, 陈捷, 王世俊, 冯旭慧. 老年2型糖尿病肾病与FGF-21、脂联素及胰岛β细胞功能的相关性分析[J]. 检验医学, 2016, 31(6): 462-466.
[6]	蒋小红. 急性心肌梗死患者血清脂联素检测的临床意义[J]. 检验医学, 2015, 30(6): 585-587.
[7]	焦路阳;王　宇;袁　宇. 冠心病患者血清内脂素和脂联素水平的变化及临床意义[J]. 检验医学, 2012, 27(5): 349-351.
[8]	张长庚;姚新洁;严香菊. 血清高分子量脂联素水平与1型糖尿病肾损伤的关系[J]. 检验医学, 2011, 26(10): 685-688.
[9]	郭翀;周海英;杨慧英;徐玉善. 脂联素与2型糖尿病及糖尿病早期肾病的相关性分析[J]. 检验医学, 2011, 26(07): 482-483.
[10]	刘敏;叶小萍. 中医综合治疗代谢综合征患者血清生化指标的改善状况[J]. 检验医学, 2011, 26(04): 246-248.
[11]	周强;杨静;周芸;吴晓蔓;罗淼珊;吕嘉春. 肥胖人群脂联素、抵抗素和胰岛素抵抗水平的研究[J]. 检验医学, 2011, 26(01): 23-26.
[12]	刘冰;范杰;高卫国;曹文艳. 乳腺癌患者血清抵抗素、脂联素和瘦素水平及其临床意义[J]. 检验医学, 2011, 26(01): 36-39.
[13]	潘逸茹;喻红之;龚立琪;薛惠君. 老年心力衰竭患者血清脂联素的测定[J]. 检验医学, 2010, 25(09): 712-714.
[14]	郭继龙;袁清;马仰国. 血清脂联素水平与脑梗死的关系研究[J]. 检验医学, 2009, 24(02): 140-142.
[15]	何云;孙丽芳;贾金侠;崔克勤. 2型糖尿病合并冠心病患者血清脂联素水平测定及临床意义[J]. 检验医学, 2008, 23(04): 374-376.